Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

AMERICAN CONTRACT SYSTEMS, INC.

US

Last updated May 23, 2026

What AMERICAN CONTRACT SYSTEMS, INC. makes

American Contract Systems, Inc. manufactures single-use, non-medicated general surgical procedure kits designed for various surgical applications. These kits are intended for one-time use in operating room settings and include essential tools and instruments required for specific surgical procedures.

The company’s products are regulated under FDA classification as either Class I or Class II devices, with some falling under the non-classifiable (N) category. These devices are listed in the FDA’s Unique Device Identifier (UDI) database, ensuring traceability and compliance with U.S. regulatory requirements.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
010334675

Catalogue (21894)

Page 435 of 438
DeviceModel / ReferenceRegistriesClassStatus
Acs LLCT75B
FDA UDI
Class IIActive
Acs MCTH68C
FDA UDI
Class IIActive
Acs IHNE35AC
FDA UDI
Class IIActive
Acs BELP05L
FDA UDI
Class IIActive
Acs UICN40AF
FDA UDI
Class IIActive
Acs CECV12AB
FDA UDI
Class IIActive
Acs UMTH19C
FDA UDI
Class IIActive
Acs PLRG56J
FDA UDI
Class IIActive
Acs HOBA16C
FDA UDI
Class IIActive
Acs BLLC42K
FDA UDI
Class IIActive
Acs MYCV98C
FDA UDI
Class IIActive
Acs FRTH63S
FDA UDI
Class IIActive
Acs TOVS55G
FDA UDI
Class IIActive
Acs VSSA12E
FDA UDI
Class IIActive
Acs AVMA31G
FDA UDI
Class IIActive
Acs GBEX53D
FDA UDI
Class IActive
Acs AGOH98S
FDA UDI
Class IIActive
Acs LLLD64K
FDA UDI
Class IIActive
Acs HHTB21E
FDA UDI
Class IIActive
Acs TMAN84E
FDA UDI
Class IIActive
Acs HKLT71B
FDA UDI
Class IIActive
Acs MHLV30D
FDA UDI
Class IIActive
Acs SHCR60D
FDA UDI
Class IIActive
Acs LSRLCSPPEA
FDA UDI
Class IIActive
Acs FHEN02Z
FDA UDI
Class IActive
Acs VETK65S
FDA UDI
Class IActive
Acs ANTK12AF
FDA UDI
Class IActive
Acs ILTJ47T
FDA UDI
Class IActive
Acs HCLC02G
FDA UDI
Class IIActive
Acs AVKA26A
FDA UDI
Class IActive
Acs MMOB91B
FDA UDI
Class IIActive
Acs EVPN63E
FDA UDI
Class IIActive
Acs UDIH90M
FDA UDI
Class IActive
Acs MHCV74H
FDA UDI
Class IIActive
Acs TOMN07O
FDA UDI
Class IIActive
Acs SCMN09C
FDA UDI
Class IIActive
Acs WPPI47G
FDA UDI
Class IIActive
Acs HSVH80D
FDA UDI
Class IIActive
Acs CDTP01D
FDA UDI
Class IIActive
Acs BESH02F
FDA UDI
Class IIActive
Acs GBEY17C
FDA UDI
Class IIActive
Acs SJTK82N
FDA UDI
Class IActive
Acs LMHU47Q
FDA UDI
Class IIActive
Acs UIMS31X
FDA UDI
Class IIActive
Acs SFMB55W
FDA UDI
Class IIActive
Acs AHTS05B
FDA UDI
Class IActive
Acs AGLO48K
FDA UDI
Class IIActive
Acs BPSA23K
FDA UDI
Class IActive
Acs SAAR74T
FDA UDI
Class IActive
Acs HSFE66K
FDA UDI
Class IActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

American Contract Systems, Inc. has 190 recall records spanning from December 28, 2016, to March 19, 2026, with statuses recorded as open, classified, or terminated. The reasons cited include concerns about incomplete sterilization, improper handling of components during sterilization processes, incorrect expiration dates, labeling errors, insufficient aeration time, and deviations from sterilization specifications. Some recalls involved third-party products or components, such as syringes from Medline Industries, and the use of FDA-banned substances in powdered surgical gloves.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 19, 2026Z-1981-2026—open, classified

Impacted kits contain syringes recalled by Medline Industries. Syringe rotating adaptor may unwind during use, which may result in a loose connection or full disconnection between the syringe and manifold. Potential risk for biohazard exposure, blood loss, infection, or air embolism.

Sep 4, 2025Z-0179-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0185-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0187-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0180-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0178-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0172-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0171-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0183-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0174-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0175-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0177-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0186-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0173-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0170-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0184-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0181-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0182-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0176-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Jul 14, 2025Z-2466-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2471-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2465-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2467-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2468-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2469-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2470-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2464-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2472-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Apr 21, 2025Z-1916-2025—open, classified

Test results for cast padding component included in procedure trays shows Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals exceeded residual limits, which may lead to a possible loss or lack of functionality that may lead to a delay or prolonged treatment/procedure/therapy.

Feb 6, 2025Z-1332-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1333-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1349-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1345-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1359-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1356-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1339-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1348-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1358-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1361-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1346-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1331-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1350-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1355-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1347-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1353-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1362-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1354-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1341-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1338-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1352-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1342-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1334-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1357-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1360-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1340-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1335-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1336-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1344-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1337-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1343-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1351-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 4, 2025Z-1406-2025—open, classified

During an internal investigation, ACS was unable to confirm that the CODMAN component achieved the required Sterility Assurance Level and therefore is not suitable for sterilization according to ACS procedures.

Jan 31, 2025Z-1425-2025—open, classified

Sterility assurance with procedure trays

Jan 31, 2025Z-1426-2025—open, classified

Sterility assurance with procedure trays

Jan 31, 2025Z-1424-2025—open, classified

Sterility assurance with procedure trays

Aug 7, 2024Z-3230-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3238-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3239-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3227-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3241-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3233-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3242-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3226-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3231-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3229-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3237-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3244-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3232-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3228-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3235-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3240-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3236-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3243-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3234-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

May 15, 2024Z-2274-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2277-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2304-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2283-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2310-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2290-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2284-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2275-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2301-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2299-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2280-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2281-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2307-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2306-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2303-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2308-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.